Citigroup Boosts Price Target on Allergan (AGN)

Citigroup Boosts Price Target on Allergan (AGN)

RSS

On Thursday analysts at Citigroup increased the price target on healthcare company Allergan, Inc. (AGN) citing continuous double digit growth in its core businesses.

The analysts back a “Buy” rating on AGN and now see shares reaching $124. This target suggests a 14% upside to Wednesday’s closing price of $108.53.

Allergan shares were down $1.44, or -1.36%, during morning trading on Thursday. The stock is up about 23% over the past year.

The Bottom Line
Shares of Allergan (AGN) have a dividend yield of 0.19% based on Thursday’s intraday trading price of $107.37 and the company’s annualized dividend payout of 20 cents per share.

Allergan, Inc. (AGN) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from Dividend.com.

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today